Staar Surgical Co (STAA)
26.68
+0.05
(+0.19%)
USD |
NASDAQ |
Nov 22, 16:00
26.90
+0.22
(+0.82%)
After-Hours: 20:00
Staar Surgical Free Cash Flow: 26.30M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 26.30M |
| June 30, 2024 | 13.55M |
| March 31, 2024 | 20.88M |
| December 31, 2023 | -3.594M |
| September 30, 2023 | -33.53M |
| June 30, 2023 | -0.534M |
| March 31, 2023 | 16.76M |
| December 31, 2022 | 17.61M |
| September 30, 2022 | 22.47M |
| June 30, 2022 | 23.68M |
| March 31, 2022 | 18.56M |
| December 31, 2021 | 30.32M |
| September 30, 2021 | 43.91M |
| June 30, 2021 | 32.41M |
| March 31, 2021 | 27.51M |
| December 31, 2020 | 12.55M |
| September 30, 2020 | 1.956M |
| June 30, 2020 | 3.642M |
| March 31, 2020 | 6.763M |
| December 31, 2019 | 15.62M |
| September 30, 2019 | 10.62M |
| June 30, 2019 | 9.062M |
| March 31, 2019 | 7.455M |
| December 31, 2018 | 10.52M |
| September 30, 2018 | 9.736M |
| Date | Value |
|---|---|
| June 30, 2018 | 4.831M |
| March 31, 2018 | 4.31M |
| December 31, 2017 | 1.807M |
| September 30, 2017 | 0.404M |
| June 30, 2017 | -1.684M |
| March 31, 2017 | 0.891M |
| December 31, 2016 | -2.156M |
| September 30, 2016 | -4.395M |
| June 30, 2016 | -4.56M |
| March 31, 2016 | -5.655M |
| December 31, 2015 | -4.207M |
| September 30, 2015 | 1.138M |
| June 30, 2015 | 0.02M |
| March 31, 2015 | -2.736M |
| December 31, 2014 | -4.207M |
| September 30, 2014 | -7.482M |
| June 30, 2014 | -4.765M |
| March 31, 2014 | -2.451M |
| December 31, 2013 | -0.093M |
| September 30, 2013 | -1.155M |
| June 30, 2013 | -1.11M |
| March 31, 2013 | 0.02M |
| December 31, 2012 | 0.946M |
| September 30, 2012 | 2.241M |
| June 30, 2012 | 2.075M |
Free Cash Flow Range, Past 5 Years
-33.53M
Minimum
Sep 2023
43.91M
Maximum
Sep 2021
14.84M
Average
17.18M
Median
Free Cash Flow Benchmarks
| The Cooper Companies Inc | 189.20M |
| OrthoPediatrics Corp | -51.07M |
| NexGel Inc | -4.054M |
| Innovative Eyewear Inc | -6.335M |
| Perspective Therapeutics Inc | -40.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.816M |
| Cash from Investing (Quarterly) | -35.24M |
| Cash from Financing (Quarterly) | 1.615M |
| Free Cash Flow Per Share (Quarterly) | -0.0486 |
| Free Cash Flow to Equity (Quarterly) | -2.415M |
| Free Cash Flow to Firm (Quarterly) | -2.415M |
| Free Cash Flow Yield | 1.99% |